Transplantation Therapeutics Research: Talks about leading products and key unmet needs within the market

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body.

Pune, India - March 14, 2018 /MarketersMedia/ —

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection.
• Identify leading products and key unmet needs within the market.
• Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935560
Scope
• There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this?
• There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market?
• How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades?
• Which molecule types and molecular targets are most prominent across transplantation therapy?
• Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935560

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/transplantation-therapeutics-research-talks-about-leading-products-and-key-unmet-needs-within-the-market/314334

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation%20%20

Source: MarketersMedia

Release ID: 314334

More News From Daily Xtreme

The Latest: Kvitova back at 1st Grand Slam final since 2014

Jan 24, 2019

MELBOURNE, Australia — The Latest at the Australian Open on Thursday (all times local): 3:45 p.m. Petra Kvitova has beaten Danielle Collins 7-6 (2), 6-0 to return to a Grand Slam final for the first time since winning the Wimbledon title in 2014. It's also the first in what she has called her "second career" following her return from injuries sustained in a home invasion in the Czech Republic in late 2016. The 28-year-old Kvitova will play for the Australian Open title against either U.S. Open champion Naomi Osaka or Karolina Pliskova. Kvitova missed the Australian Open in 2017 while...

Vogue editor joins push to re-name Margaret Court Arena

Jan 24, 2019

MELBOURNE, Australia — Vogue editor Anna Wintour has added her voice to those calling for the renaming of Margaret Court Arena at the Australian Open because of the tennis great's outspoken condemnation of same-sex marriage. Wintour is an avid tennis fan who has been at Melbourne Park this week and spent time in the stadium player boxes of Serena Williams and Roger Federer She used a speech at an Australian Open function on Thursday to raise the issue. "I find that it is inconsistent with the sport for Margaret Court's name to be on a stadium that does so much...

Peers, Kontinen 1st into men's doubles final in Australia

Jan 24, 2019

MELBOURNE, Australia — John Peers and Henri Kontinen have combined to become the first pair through to the men's doubles final after beating Leonardo Mayer and Joao Sousa 6-1, 7-6 (6) at the Australian Open. Peers and Kontinen, who combined to win the 2017 Australian Open doubles title, will play either the American team of Ryan Harrison and Sam Querrey or the French combination of Pierre-Hugues Herbert and Nicolas Mahut. The women's singles finalists will be determined later Thursday. Two-time Wimbledon winner Petra Kvitova was playing Danielle Collins in the first of the semifinals on Rod Laver Arena, followed by...

50 years past last men's Slam, Laver says it'll happen again

Jan 24, 2019

MELBOURNE, Australia — Fifty years after Rod Laver won the last true Grand Slam in men's tennis, he is fairly confident the feat will be replicated one day, unlikely as it may seem. "It's got to happen again," the Australian left-hander said Wednesday at the Australian Open. While Steffi Graf won all four major tennis tournaments in one season in 1988, no man has done it other than Don Budge in 1938 and Laver in 1962 and 1969. Serena Williams and Novak Djokovic each managed to collect four major trophies in a row but spread out over two seasons. Laver's...

Column: Don't write off Serena or Federer just yet

Jan 24, 2019

MELBOURNE, Australia — Tempting as it might be, don't write off Serena Williams or Roger Federer just yet. Sure, both are 37, and they're showing their age. Yes, both are gone from the Australian Open, each with a loss to a far-younger opponent. Williams exited Wednesday in the quarterfinals against 26-year-old Karolina Pliskova of the Czech Republic after wasting four match points and a 5-1 lead in the third set; Federer went out Sunday in the fourth round against 20-year-old Stefanos Tsitsipas of Greece. And, well, there also are these facts to consider: — Federer failed to make it to...

NHL Livescore